# Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment

> **NCT04118049** · NA · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 141 (actual)

## Conditions studied

- Pelvic Organ Prolapse
- Inflammatory Response
- Dysbiosis

## Interventions

- **OTHER:** BiopHreshTM vaginal probiotic supplement (Good Clean Love, Inc. Eugene, OR) and RestoreTM gel.
- **OTHER:** Standard Care

## Key facts

- **NCT ID:** NCT04118049
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-30
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-05-30
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2022-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04118049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04118049, "Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04118049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*